Skip to main content

Santiago Ramon y Cajal Agüeras

Institutions of which they are part

Head of group
Translational Molecular Pathology
Vall Hebron Institut de Recerca

Santiago Ramon y Cajal Agüeras

Institutions of which they are part

Head of group
Translational Molecular Pathology
Vall Hebron Institut de Recerca

Projects

Determinación de nuevos factores pronóstico y diagnóstico en cáncer basados en microRNAs.

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Laia Perez Lasarte
Funding agency: Instituto de Salud Carlos III
Funding: 54000
Reference: FI12/00483
Duration: 04/09/2012 - 03/09/2016

Red Temática de Investigación Cooperativa en Cáncer (RTICC)

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Cleofé Romagosa Pérez-Portabell, Maria Rosa Somoza Lopez de Haro, Meritxell Bellet Ezquerra, Cristina Saura Manich, Angel García Jiménez, Patricia Gómez Pardo, Red Temática de Investigación Cooperativa en Cáncer (RTICC), Teresa Moline Marimon, Josep Castellví Vives, Judith Balmaña Gelpí, Pere Barba Suñol, Eva Muñoz Couselo, Javier Hernandez Losa, Marta Sese Faustino, Vicente Peg Camara, Stefania Landolfi , Trond Aasen
Funding agency: Instituto de Salud Carlos III
Funding: 209700
Reference: RD12/0036/0057
Duration: 01/01/2013 - 30/06/2017

Estudio del factor elF4E y factores de la vía de síntesis de proteínas cap-independiente en tumores humanos: correlación con hipoxia, pronóstico e identificación de dianas terapéuticas

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Maria Rosa Somoza Lopez de Haro, Josep Castellví Vives, Maria Teresa Salcedo Allende, Vicente Peg Camara
Funding agency: Instituto de Salud Carlos III
Funding: 196130.11
Reference: PI11/00185
Duration: 01/01/2012 - 31/12/2014

Identificación de nuevas dianas para el tratamiento del cáncer basada en el estudio de factores cap-independientes activados en tumores malignos

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Maria Rosa Somoza Lopez de Haro, Teresa Moline Marimon, Josep Castellví Vives, Maria Teresa Salcedo Allende, Javier Hernandez Losa, Vicente Peg Camara, Trond Aasen
Funding agency: Fundación Invest. Médica Mutua Madrileña
Funding: 9283
Reference: FMM-2011-11
Duration: 01/09/2011 - 31/08/2012

Related news

The ten groups within the Cancer Area combine basic, translational and clinical research to identify new targets, biomarkers and therapeutic strategies

The grants promote new therapeutic strategies and diagnostic tools in highly complex tumors such as glioblastoma, triple-negative breast cancer, and endometrial cancer.

The Department of Health of the Generalitat de Catalunya grants subsidies for carrying out validation tests on innovative projects in the field of health that are in the early stages of development.

Related professionals

Patricia Pérez Badillo

Patricia Pérez Badillo

Research assistant
Multidisciplinary Nursing Research Group
Read more
Ferran Blasco Casado

Ferran Blasco Casado

Postdoctoral researcher
Reconstructive Surgery of the Locomotor System
Read more
Clara Serra Marrugat

Clara Serra Marrugat

Predoctoral researcher
Childhood Cancer and Blood Disorders
Read more
Joel Lara Consuegra

Joel Lara Consuegra

Technological Infrastructure Unit
Digital Transformation Directorate
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.